Holding types
Countries
Sectors
Analyst ratings
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FAQ
- What is BOUT ETF?
- Does BOUT pay dividends?
- What stocks are in BOUT ETF?
- What is the current assets under management for BOUT?
- What is BOUT average volume?
- What is BOUT expense ratio?
- What is BOUT inception date?
What is BOUT ETF?
BOUT ETF is an exchange-traded fund that focuses on companies involved in the biotechnology sector. It aims to provide investors with exposure to innovative biotech firms, offering potential growth opportunities in healthcare and drug development. The fund is designed for those interested in the biotech industry's advancements.
Does BOUT pay dividends?
Yes, the Innovator IBD Breakout Opportunities ETF does pays dividends, with
the most recent payment being
$0.23
per share. The last ex-dividend date was on 31 December 2024, and the next ex-dividend date has not been announced yet
What stocks are in BOUT ETF?
As of today, Innovator IBD Breakout Opportunities ETF inlcudes 27 holdings, with 25 of them being companies from 6 different countries and 7 sectors. The most weighted holdings are Twilio (7.16%), Planet Fitness (6.95%) and Expedia (6.91%)
What is the current assets under management for BOUT?
Assets under management of Innovator IBD Breakout Opportunities ETF is $15 M
What is BOUT average volume?
Average volume of Innovator IBD Breakout Opportunities ETF is $3092
What is BOUT expense ratio?
Expense ratio of Innovator IBD Breakout Opportunities ETF is 0.80%
What is BOUT inception date?
Inception date of Innovator IBD Breakout Opportunities ETF is 13 September 2018